CORONA Remedies Limited
Promoter holding in CORONA Remedies Limited has stayed unchanged at 69.00% for the last 5 quarters on record (since Sep 2025).
By quarter
Quarter by quarter
| Quarter | Promoters | Public |
|---|---|---|
| Sep '26 | 69.00%=0.00 | 31.00%=0.00 |
| Jun '26 | 69.00%=0.00 | 31.00%=0.00 |
| Mar '26 | 69.00%=0.00 | 31.00%=0.00 |
| Dec '25 | 69.00%=0.00 | 31.00%=0.00 |
| Sep '25 | 69.00% | 31.00% |
Compared with similar companies
Promoter holding in CORONA Remedies Limited is higher than 79% of companies in the Healthcare sector in India.
| Company | Promoters |
|---|---|
| CORONA Remedies Limited | 69.00% |
| Sun Pharmaceutical Industries Limited | 54.48% |
| Divi's Laboratories Limited | 51.88% |
| Torrent Pharmaceuticals Limited | 60.78% |
| Zydus Lifesciences Limited | 75.01% |
| Apollo Hospitals Enterprise Limited | 28.02% |
Similar-sized companies in the same sector, latest quarter on record.
Questions
What is CORONA Remedies Limited's promoter holding?
Promoters held 69.00% of CORONA Remedies Limited as of 30 Sep 2026, and the public held 31.00%.
Has CORONA Remedies Limited's promoter holding increased?
No, it was unchanged in the quarter to Sep 2026.
Are any promoter shares of CORONA Remedies Limited pledged?
No promoter shares are recorded as pledged.
How does CORONA Remedies Limited's promoter holding compare with similar companies?
Promoter holding in CORONA Remedies Limited is higher than 79% of companies in the Healthcare sector in India. A higher or lower promoter holding is not good or bad by itself.
From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.